SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000827871-23-000009
Filing Date
2023-03-23
Accepted
2023-03-23 16:55:20
Documents
95
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K egrx-20221231.htm   iXBRL 10-K 2604966
2 EX-21 exhibit21110k2022.htm EX-21 4764
3 EX-23 exhibit23110k2022.htm EX-23 3542
4 EX-31.1 exhibit31110k2022.htm EX-31.1 8953
5 EX-31.2 exhibit31210k2022.htm EX-31.2 8939
6 EX-32 exhibit32110k2022.htm EX-32 7459
12 egrx-20221231_g1.jpg GRAPHIC 152159
  Complete submission text file 0000827871-23-000009.txt   12016326

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20221231.xsd EX-101.SCH 68138
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20221231_cal.xml EX-101.CAL 140273
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20221231_def.xml EX-101.DEF 370432
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20221231_lab.xml EX-101.LAB 918645
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20221231_pre.xml EX-101.PRE 614435
89 EXTRACTED XBRL INSTANCE DOCUMENT egrx-20221231_htm.xml XML 1861979
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36306 | Film No.: 23756904
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences